ReP USP - Resultado da busca

Filtros : "Janse, Chris J." Removido: "Penha-Gonçalves, Carlos" Limpar

Filtros

USP affiliated authors
- marques, rodolfo ferreira (~1)
- obando, hernando antonio del portillo (~1)
- soares, irene da silva (~1)
Date published
- 2021 (~1)
- 2003 (~1)
Subjects
- adjuvantes imunológicos (1)
- malária (1)
- parasitologia (1)
- plasmodium malariae (1)
- proteínas recombinantes (1)

Artigo de periodico
A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles (2021)
Gimenez, Alba Marina ; Salman, Ahmed M ; Marques, Rodolfo Ferreira ; Camacho, Cesar Lopez ; Harrison, Kate ; Kim, Young Chan ; Janse, Chris J. ; Soares, Irene da Silva ; Sandoval, Arturo Reyes
Source: Scientific Reports. Unidade: FCF
Subjects: MALÁRIA, VACINAS, PROTEÍNAS RECOMBINANTES, ADJUVANTES IMUNOLÓGICOS, PLASMODIUM MALARIAE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIMENEZ, Alba Marina et al. A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles. Scientific Reports, v. 11, p. 1-14 art. 17928, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41598-021-96986-1. Acesso em: 20 ago. 2024.
APA
Gimenez, A. M., Salman, A. M., Marques, R. F., Camacho, C. L., Harrison, K., Kim, Y. C., et al. (2021). A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles. Scientific Reports, 11, 1-14 art. 17928. doi:10.1038/s41598-021-96986-1
NLM
Gimenez AM, Salman AM, Marques RF, Camacho CL, Harrison K, Kim YC, Janse CJ, Soares I da S, Sandoval AR. A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles [Internet]. Scientific Reports. 2021 ; 11 1-14 art. 17928.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1038/s41598-021-96986-1
Vancouver
Gimenez AM, Salman AM, Marques RF, Camacho CL, Harrison K, Kim YC, Janse CJ, Soares I da S, Sandoval AR. A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles [Internet]. Scientific Reports. 2021 ; 11 1-14 art. 17928.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1038/s41598-021-96986-1
Artigo de periodico
Malaria parasites lacking eef1a have a normal S/M pahse yet grow more slowly due to a longer G1 phase (2003)
Janse, Chris J.; Haghparast,Alireza; Sperança, Márcia A.; Ramesar, Jai; Kroeze, Hans; Obando, Hernado Antonio Del Portillo; Waters, Andrew P.
Source: Molecular Microbiology. Unidade: ICB
Assunto: PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANSE, Chris J. et al. Malaria parasites lacking eef1a have a normal S/M pahse yet grow more slowly due to a longer G1 phase. Molecular Microbiology, v. 50, p. 1539-1551, 2003Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2958.2003.03820.x. Acesso em: 20 ago. 2024.
APA
Janse, C. J., Haghparast, A., Sperança, M. A., Ramesar, J., Kroeze, H., Obando, H. A. D. P., & Waters, A. P. (2003). Malaria parasites lacking eef1a have a normal S/M pahse yet grow more slowly due to a longer G1 phase. Molecular Microbiology, 50, 1539-1551. doi:10.1046/j.1365-2958.2003.03820.x
NLM
Janse CJ, Haghparast A, Sperança MA, Ramesar J, Kroeze H, Obando HADP, Waters AP. Malaria parasites lacking eef1a have a normal S/M pahse yet grow more slowly due to a longer G1 phase [Internet]. Molecular Microbiology. 2003 ; 50 1539-1551.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1046/j.1365-2958.2003.03820.x
Vancouver
Janse CJ, Haghparast A, Sperança MA, Ramesar J, Kroeze H, Obando HADP, Waters AP. Malaria parasites lacking eef1a have a normal S/M pahse yet grow more slowly due to a longer G1 phase [Internet]. Molecular Microbiology. 2003 ; 50 1539-1551.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1046/j.1365-2958.2003.03820.x

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024